中国·亚星-www.333.com|百家乐官方网

Current Location：Home Investor RelationsDisclosure

Announcements and Circulars

222024.11
DISCLOSEABLE TRANSACTIONS IN RELATION TO SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS

Show More
062024.11
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Show More
052024.11
INSIDE INFORMATION ANNOUNCEMENT QX001S (SAILEXIN, USTEKINUMAB INJECTION) DRUG REGISTRATION CERTIFICATE APPROVED AND ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Show More
282024.10
ACCEPTANCE BY THE CSRC OF APPLICATION FOR THE COMPANY'S H SHARE FULL CIRCULATION PLAN

Show More
252024.10
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Show More
252024.10
(1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 25, 2024 (2) APPOINTMENT OF DIRECTORS OF THE SECOND SESSION OF THE BOARD (3) APPOINTMENT OF NON-EMPLOYEE REPRESENTATIVE SUPERVISORS OF THE SECOND SESSION OF THE SUPERVISORY COMMITTEE (4) ELECTION OF THE CHAIRMAN OF THE SECOND SESSION OF THE BOARD AND MEMBERS OF SPECIAL COMMITTEES (5) ELECTION OF THE CHAIRMAN OF THE SECOND SESSION OF THE SUPERVISORY COMMITTEE AND (6) RE-APPOINTMENT OF GENERAL MANAGER

Show More

9 10 11 12 13 14 ... 18